UHPLC-TOF-MS结合网络药理学与分子对接探讨人参-酸枣仁药对治疗帕金森的作用机制

    Mechanism of Ginseng Radix et Rhizoma-Ziziphi Spinosae Semen in Treatment of Parkinson’s Disease Based on UHPLC-TOF-MS, Network Pharmacology and Molecular Docking

    • 摘要:
      目的 基于超高效液相色谱串联飞行时间质谱(UHPLC-TOF-MS)、网络药理学及分子对接技术,探讨人参-酸枣仁药对治疗帕金森的作用机制。
      方法 采用UHPLC-TOF-MS对人参-酸枣仁药对入血成分进行定性分析。采用SwissTargetPrediction、Gene Cards等数据库获取入血成分及疾病相关靶点,取交集后构建蛋白互作(protein-protein interaction,PPI)网络,筛选核心靶点并进行GO功能和KEGG通路富集分析。采用Cytoscape 3.10.0软件构建“化合物-靶点-通路”网络,预测人参-酸枣仁药对治疗帕金森的作用靶点。采用Auto Dock软件对关键靶点及活性成分进行分子对接验证。此外,基于SH-SY5Y细胞模型,进一步验证人参皂苷Rg1和莲心季铵碱对MPP诱导损伤的保护作用。采用CCK-8检测细胞存活率,并通过TUNEL荧光染色评估细胞凋亡情况。
      结果 共鉴定人参-酸枣仁药对入血成分20个,主要包含三萜皂苷类、生物碱类等化合物。PPI分析筛选关键靶点78个,KEGG富集分析发现人参-酸枣仁药对可能通过PI3K-Akt、Rap1、Prolactin等信号通路发挥治疗帕金森的作用。分子对接结果显示,关键靶点MAPK1、AKT1、MAPK8、HRAS、EGFR与人参-酸枣仁药对中活性成分人参炔B、人参皂苷Rg1、酸李碱、人参皂苷Rf、莲心季铵碱结合良好。细胞实验结果显示,与模型组相比,人参皂苷Rg1和莲心季铵碱均能提高细胞存活率,减少TUNEL阳性细胞比例,且联合使用具有更显著的保护作用。
      结论 人参-酸枣仁药对可通过多成分、多靶点、多通路协同发挥治疗帕金森的作用,且其代表核心成分在人神经元细胞模型中表现出保护作用。

       

      Abstract:
      OBJECTIVE To explore the mechanism of Ginseng Radix et Rhizoma-Ziziphi Spinosae Semen in treatment of Parkinson’s disease based on UHPLC-TOF-MS, network pharmacology and molecular docking technologies.
      METHODS UHPLC-TOF-MS was used to qualitatively identify the constituents of Ginseng Radix et Rhizoma-Ziziphi Spinosae Semen migrated into blood. Targets of the plasma constituents and the disease associated target were retrieved from Swiss Target Prediction and Gene Cards. Then the protein-protein interaction(PPI) network was constructed and core targets were screened for GO term enrichment and KEGG pathway enrichment. Cytoscape 3.10.0 was employed to construct the “compound-target-pathway” network and the targets of Ginseng Radix et Rhizoma-Ziziphi Spinosae Semen against Parkinson’s disease were predicted. The Auto Dock software was used for molecular docking analysis of key targets and active ingredients. Additionally, an SH-SY5Y cell model was used to further verify the protective effects of ginsenoside Rg1 and lotusine against MPP-induced damage. Cell viability was assessed using the CCK-8 assay, and apoptosis was evaluated by TUNEL fluorescence staining.
      RESULTS A total of 20 constituents of Ginseng Radix et Rhizoma-Ziziphi Spinosae Semen migrated into blood were identified, mainly including triterpenoid saponins and alkaloids. The 78 key targets were screened out by PPI. KEGG enrichment showed that Ginseng Radix et Rhizoma-Ziziphi Spinosae Semen might play a role in treatment of Parkinson’s disease through PI3K-Akt, Rap1, Prolactin and other pathways. Molecular docking results showed that key targets MAPK1, AKT1, MAPK8, HRAS, EGFR could be well combined by core active constituents ginsenoyne B, ginsenoside Rg1, zizyphusine, ginsenoside Rf, lotusine, respectively. Cell experiments showed that compared with the model group, ginsenoside Rg1 and lotusine significantly increased cell viability, reduced the proportion of TUNEL-positive cells, and exhibited more pronounced protective effects when used in combination.
      CONCLUSION Ginseng Radix et Rhizoma-Ziziphi Spinosae Semen can play a role in the prevention and treatment of Parkinson’s disease through multiple components, targets and pathways. Furthermore, its representative core components demonstrate neuroprotective effects in a human neuronal cell model.

       

    /

    返回文章
    返回